Nehi (/ ˈniːhaɪ / NEE-hy[2]) is a flavored soft drink that originated in the United States. It was introduced in 1924 by Chero-Cola/Union Bottle Works and founded by Claud A. Hatcher, a Columbus, Georgia, grocer who began bottling ginger ale and root beer in 1905. [1]

NEHI is a relatively rare disorder of the lungs that was first classified and described in 2005. As a result, it is difficult to estimate the number of children with this disorder in the US. However, this is one of the most common forms of chILD and is still underdiagnosed.

2023年1月16日 · Yes, Nehi is still being produced and sold today. Nehi is a brand of fruit-flavored, carbonated soft drinks that are made by the Royal Crown Cola company and are known for their refreshing, fruity taste.

Nehi Grape soda is boldly refreshing with sweet grape flavor. The Nehi soda variety pack is ideal for any fruit flavored soda lover, and is perfect for those who seek a superior, caffeine free soft drink selection.

Neuroendocrine cell hyperplasia of infancy (NEHI), initially described as persistent tachypnea of infancy, is a rare lung disease first defined in 2005 [1]. The etiology is unknown, but genetic mechanisms may play a role.

Neuroendocrine cell hyperplasia of infancy (NEHI) is a common form of childhood interstitial lung disease. A high‐resolution CT scan is a useful and major imaging approach for assisting in diagnosis. The major characteristics of NEHI on CT are the presence of typical ground glass opacities and air trapping.

Neuroendocrine cell hyperplasia of infancy (NEHI) is a form of children’s interstitial and diffuse lung disease (chILD). It was initially named persistent tachypnea of infancy (1) and subsequently NEHI, after biopsy findings of increased numbers of neuroendocrine cells in …

NEHI has been found to run in some families so it suggests there is some genetic basis for this disorder. However, a gene abnormality has not been identified. Environmental causes may …

2023年7月7日 · 婴儿神经内分泌细胞增生症 (neuroendocrine cell hyperplasia of infancy, NEHI)是一种罕见肺病，最初称为婴儿持续性呼吸急促症，于2005年首次定义 [1]。 其病因不明，但可能与遗传学机制有关。 NEHI通常在无其他健康问题的婴儿出生后数月至1年发病，表现为持续呼吸急促、湿啰音和低氧血症。 胸部CT的典型表现包括呈特征性分布的过度充气和磨玻璃影，无其他实质异常。 肺部症状和低氧血症往往逐渐改善，但可持续数年。 本专题将讨论NEHI的临床表现、 …

2023年4月18日 · 婴儿神经内分泌细胞增生症（neuroendocrine cell hyperplasia of infancy， NEHI）是一种成熟不良的婴儿间质性肺疾病。 NEHI的病因不明，临床上以呼吸急促、三凹征、爆裂音和低氧血症为特点。 病理诊断主要靠蛙皮素的免疫组化，远端气道神经内分泌细胞（neuroendocrine cells， NECs）数目增加， NECs存在于至少75%的气道；在每一气道中NECs占10%；缺乏其他气道和间质疾病的特征，肺高分辨肺CT的特征为中心型的磨玻璃影， …